Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC

(2016) Anja Katholing et al.   THROMBOSIS AND HAEMOSTASIS

Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review

(2015) Boris Arbit et al.   CLINICAL CARDIOLOGY

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban

(2015) Sally Tamayo et al.   CLINICAL CARDIOLOGY

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation

(2015) A. John Camm et al.   EUROPACE

Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence

(2015) B. Vrijens et al.   EUROPACE

Adherence to Oral Anticoagulation in Secondary Stroke Prevention—The First Year of Direct Oral Anticoagulants

(2015) Roland Sauer et al.   Journal of Stroke & Cerebrovascular Diseases

Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study

(2015) H.-Y. Chang et al.   BMJ-British Medical Journal

Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study

(2015) H.-Y. Chang et al.   BMJ-British Medical Journal

Adherence to Oral Anticoagulation in Secondary Stroke Prevention—The First Year of Direct Oral Anticoagulants

(2015) Roland Sauer et al.   Journal of Stroke & Cerebrovascular Diseases

Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation

(2014) S. Ben Freedman et al.   EUROPEAN HEART JOURNAL

High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke

(2014) Leif Friberg et al.   STROKE

Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

(2013) Irene Savelieva et al.   CLINICAL CARDIOLOGY

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Adherence to anticoagulant treatment with dabigatran in a real-world setting

(2013) S. Schulman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

(2012) Tara Gomes et al.   ARCHIVES OF INTERNAL MEDICINE

Effect of dosing frequency on chronic cardiovascular disease medication adherence

(2012) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Outcomes for Patients with Ischaemic Stroke and Atrial Fibrillation: The PRISM Study (A Program of Research Informing Stroke Management)

(2011) Melina Gattellari et al.   CEREBROVASCULAR DISEASES

Secondary preventive medication persistence and adherence 1 year after stroke

(2011) C. D. Bushnell et al.   NEUROLOGY

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation

(2007) Melina Gattellari et al.   STROKE